Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Colombiana de Reumatología
Print version ISSN 0121-8123
Abstract
TOBON T, Manuela et al. Adalimumab-induced cutaneous lupus. Rev.Colomb.Reumatol. [online]. 2016, vol.23, n.4, pp.271-274. ISSN 0121-8123. https://doi.org/10.10167j.rcreu.2016.10.001.
Tumor necrosis factor inhibitors have become one of the most important treatments of rheumatoid arthritis. Adalimumab is a monoclonal antibody used for the treatment of this condition. A case is described of adalimumab induced cutaneous lupus.
Keywords : Adalimumab; Cutaneous lupus erythematosus; Rheumatoid arthritis.